{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:28:03Z","timestamp":1761766083845},"reference-count":31,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2016,5,17]],"date-time":"2016-05-17T00:00:00Z","timestamp":1463443200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Deutsche Forschungsgemeinschaft, Klinische Forschergruppe \u201cPlatelet-Basic Mechanisms and Translational Medicine\u201d","award":["KFO274"],"award-info":[{"award-number":["KFO274"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cathet Cardio Intervent"],"published-print":{"date-parts":[[2016,9]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>The aim of this study was to compare the 30\u2010day procedural, clinical and echocardiographic outcome of the new balloon\u2010expandable Edwards Sapien 3 (ES3) valve with the Edwards Sapien XT (ESXT). <jats:bold>Background<\/jats:bold>: Post\u2010implant paravalvular leaks (PVL) after transfemoral aortic valve replacement (TAVR) resulting in residual aortic regurgitation (AR) are a major limitation for long term outcome. New TAVR\u2010devices have to eliminate this problem.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Transfemoral TAVR was performed in 209 consecutive intermediate\u2010high\u2010risk surgical patients (pts) with symptomatic aortic stenosis (ESXT <jats:italic>n<\/jats:italic>\u2009=\u2009102, ES3 <jats:italic>n<\/jats:italic>\u2009=\u2009107). Transthoracic echocardiography (TTE) and 3\u2010dimensional computed tomography were used for valve size selection. Primary endpoint of the study was none\/trace AR derived by TTE 30\u2010days after TAVR.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>All pts underwent successfully TAVR with a combined device success of 100\/102 (99%) in ESXT and 107\/107 (100%) in ES3 pts. Fluoroscopy time (ESXT 11.8\u2009\u00b1\u20090.5 min vs. ES3 10.0\u2009\u00b1\u20090.5 min, <jats:italic>P<\/jats:italic>\u2009=\u20090.003) and contrast (ESXT 188.9\u2009\u00b1\u20095.6 mL vs. ES3 170.4\u2009\u00b1\u20094.7 mL, <jats:italic>P<\/jats:italic>\u2009=\u20090.04) were significantly lower in ES3 patients. 30\u2010day clinical events did not differ. Transvalvular mean pressure gradients were significantly reduced to 7.4\u2009\u00b1\u20090.8 mmHg after ESXT and to 10.1\u00b1 0.4 mmHg after ES3 implantation. After 30 days none\/trace AR was found in 34.3% (<jats:italic>n<\/jats:italic>\u2009=\u200935) of all ESXT pts in contrast to 89.7% (<jats:italic>n<\/jats:italic>\u2009=\u200996) of all ES3 patients. Moderate\u2010to\u2010severe AR was found rarely (ESXT 2.9% vs. ES3 0%, <jats:italic>P<\/jats:italic>\u2009=\u20090.073).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Although there was no significant difference in 30 day mortality, the newer ES3 valve reduced significantly residual paravalvular leakage. \u00a9 2016 Wiley Periodicals, Inc.<\/jats:p><\/jats:sec>","DOI":"10.1002\/ccd.26562","type":"journal-article","created":{"date-parts":[[2016,5,17]],"date-time":"2016-05-17T06:07:25Z","timestamp":1463465245000},"page":"466-475","source":"Crossref","is-referenced-by-count":10,"title":["Clinical outcome and paravalvular leakage of the new balloon\u2010expandable Edwards Sapien 3 valve in comparison to its predecessor model (Edwards Sapien XT) in patients undergoing transfemoral aortic valve replacement"],"prefix":"10.1002","volume":"88","author":[{"given":"Wolfgang","family":"Bocksch","sequence":"first","affiliation":[{"name":"Department of Medicine III (Cardiovascular Disease) Eberhard\u2010Karls\u2010Universitaet Tuebingen  Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benita","family":"Grossmann","sequence":"additional","affiliation":[{"name":"Department of Medicine III (Cardiovascular Disease) Eberhard\u2010Karls\u2010Universitaet Tuebingen  Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Geisler","sequence":"additional","affiliation":[{"name":"Department of Medicine III (Cardiovascular Disease) Eberhard\u2010Karls\u2010Universitaet Tuebingen  Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Steeg","sequence":"additional","affiliation":[{"name":"Department of Medicine III (Cardiovascular Disease) Eberhard\u2010Karls\u2010Universitaet Tuebingen  Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Droppa","sequence":"additional","affiliation":[{"name":"Department of Medicine III (Cardiovascular Disease) Eberhard\u2010Karls\u2010Universitaet Tuebingen  Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rezo","family":"Jorbenadze","sequence":"additional","affiliation":[{"name":"Department of Medicine III (Cardiovascular Disease) Eberhard\u2010Karls\u2010Universitaet Tuebingen  Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Haap","sequence":"additional","affiliation":[{"name":"Department of Medicine IV Eberhard\u2010Karls\u2010Universitaet Tuebingen  Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meinrad","family":"Gawaz","sequence":"additional","affiliation":[{"name":"Department of Medicine III (Cardiovascular Disease) Eberhard\u2010Karls\u2010Universitaet Tuebingen  Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Fateh\u2010Moghadam","sequence":"additional","affiliation":[{"name":"Department of Medicine III (Cardiovascular Disease) Eberhard\u2010Karls\u2010Universitaet Tuebingen  Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,5,17]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1008232"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.02.556"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1103510"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1400590"},{"key":"e_1_2_6_6_1","unstructured":"LeonMB for the PARTNER II Investigators. A randomized evaluation of the SAPIEN XT transcatheter valve system in patients with aortic stenosis who are not candidates for surgery: PARTNER II inoperable cohort. Paper presented at the 62ndAnnual Scientific Session of the American College of Cardiology; March 10 2013; San Francisco."},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1200384"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu384"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2012.09.019"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2014.07.019"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.09.001"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.02.537"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezs455"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcct.2012.11.002"},{"key":"e_1_2_6_15_1","first-page":"328","article-title":"Assessment of a novel software tool in the selection of aortic valve prosthesis size for transcatheter aortic valve replacement","volume":"26","author":"Vaitkus PT","year":"2014","journal-title":"J Invasive Cardiol"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2012.12.005"},{"key":"e_1_2_6_17_1","first-page":"451","article-title":"Standardized methodology for transfemoral transcatheter aortic valve replacement with the Edwards Sapien XT valve under fluoroscopy guidance","volume":"26","author":"Kasel AM","year":"2014","journal-title":"J Invasive Cardiol"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/ejechocard\/jen303"},{"key":"e_1_2_6_19_1","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","article-title":"Chamber Quantification Writing Group, American Society of Echocardiography's Guidelines and Standards Committee, European Association of Echocardiography. Recommendation for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with European Association of echocardiography, a branch of the European Society of cardiology","volume":"18","author":"Lang RM","year":"2005","journal-title":"J Am Soc Echocardiogr"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.02.087"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.09.026"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.3316"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.06.026"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.110981"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.07.003"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8183.2012.00729.x"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehp552"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/joic.12165"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.005479"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2014.10.014"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.10.013"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.4244\/EIJV9I11A216"}],"container-title":["Catheterization and Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fccd.26562","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ccd.26562","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T16:56:08Z","timestamp":1695488168000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ccd.26562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,17]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["10.1002\/ccd.26562"],"URL":"https:\/\/doi.org\/10.1002\/ccd.26562","archive":["Portico"],"relation":{},"ISSN":["1522-1946","1522-726X"],"issn-type":[{"value":"1522-1946","type":"print"},{"value":"1522-726X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,17]]}}}